Effect of Vasopressin vs Norepinephrine on Pulmonary Oxygenation and Lung Mechanics in Patients With Hypertension Therapy During One-lung Ventilation : Preliminary Study

NCT04170751 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypertension

Interventions

DRUG: 16 mcg / cc of norepinephrine(group N)
DRUG: 0.4 unit / cc of vasopressin(group V)

Sponsor

Yonsei University